Pernix Therapeutics Balance Sheet - Quarterly (NASDAQ:PTX)

Add to My Stocks
$2.47 $0.02 (0.8%) PTX stock closing price Mar 20, 2018 (Closing)

A thorough fundamental analysis involves using data from Pernix Therapeutics balance sheet, apart from other financial statements, to value the business. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Pernix Therapeutics stock analysis, and provides insights into the firm's financial performance. Quarterly results are typically accompanied with the company releasing financial statements. Pernix Therapeutics had a long term debt of $50.03M at the end of 2017 Q3. To understand the debt servicing capacity of the company, one needs to look at Pernix Therapeutics operating cash flow and Pernix Therapeutics revenue also. Pernix Therapeutics debt to equity ratio is -.

View and download Pernix Therapeutics quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Marketable Securities---------
Raw Materials1.73M1.87M1.97M2.36M1.5M1.78M1.84M2.04M1.89M
Work In Progress------1.45M1.42M2.26M
Finished Goods6.87M7.31M6.73M7.39M9.73M11.4M11.98M9.01M8.67M
Notes Receivable---------
Other Current Assets8.81M13.31M15.06M12.61M13.25M11.65M12.11M13.28M27.76M
Total Current Assets
Property Plant & Equipment---1.8M---2.81M-
Accumulated Depreciation---------
Net Property Plant & Equipment
Investment & Advances---------
Other Non-Current Assets---------
Deferred Charges---------
Deposits & Other Assets2.4M------10.6M14.6M
Total Assets
Notes Payable11.1M15.04M-------
Accounts Payable22.69M23.09M20.39M7.27M23.13M-37.4M14.08M42.58M
Current Portion Long-Term Debt-14M-------
Current Portion Capital Leases---------
Accrued Expenses58.25M55.73M55.81M75.02M56.35M81.42M62.48M76.36M57.95M
Income Taxes Payable---------
Other Current Liabilities12.66M16.17M11.24M16.12M11M15.68M21.3M28.65M16.65M
Total Current Liabilities
Deferred Taxes/Income--------1M
Convertible Debt64.87M106.37M105.21M104.07M102.95M101.87M100.81M103.8M102.95M
Long-Term Debt50.03M173.1M14M14M198M198.2M203.27M209.94M209.9M
Non-Current Capital Leases---------
Other Long-Term Liabilities176.32M21.71M195.97M196.9M11.92M11.25M15.28M29.95M44.15M
Total Liabilities
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus259.79M245.71M245.05M244.3M242.16M240.88M228.3M226.83M225.2M
Retained Earnings-403.11M-409.47M-387.85M-358.39M-272.31M-245.87M-214.73M-188.8M-107.13M
Treasury Stock-----5.57M5.56M5.54M5.54M
Other Liabilities-0.04M-0.05M-0.07M-0.07M-0.01M----
Shareholders Equity-143.24M-163.71M-142.77M-114.06M-30.06M-9.71M8.61M33.09M113.13M
Total Liabilities & Shareholders Equity241.6M246.48M259.86M310.44M374.16M402.74M449.24M511.15M598.44M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Pernix Therapeutics stock price, and Pernix Therapeutics historical stock prices show the stock price movement over time, and the Pernix Therapeutics PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Pernix Therapeutics owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for PTX stock as of 2017 Q3 is $241.6M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. PTX stock had total liabilities of $384.85M for the quarter 2017 Q3.

Pernix Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover